miR News & Events

Press Releases

October 30, 2023

miR Scientific’s CLIA Laboratory Receives Accreditation from the College of American Pathologists (CAP)

August 18, 2022

miR Scientific launches "Can do Blue" on September 1, 2022, as Prostate Cancer Awareness Month

July 13, 2022

miR Scientific is proud to announce the commercial availability of the miR Sentinel™ Prostate Cancer Test

March 27, 2022

miR Scientific and Leonie Hill Capital Announce Collaboration to Introduce Breakthrough Urine Liquid Biopsy Prostate Cancer Test in Singapore

November 17, 2021

Jim Roosevelt, Health Plan Executive, Joins miR Scientific as Advisory Board Member

November 5, 2021

miR Sentinel™ Press Release

September 30, 2021

Noninvasive miR Sentinel PCC4 Test accurately identifies prostate cancer

September 20, 2021

miR Scientific Presents Groundbreaking Data on the Exceptional Accuracy of its Prostate Cancer Liquid-Biopsy Test

September 1, 2021

miR Scientific and Puerto Rico Government team up for Prostate Cancer Prevention Day, to battle the number one cause of cancer-related death among men in the island

September 1, 2021

miR Scientific y el Gobierno de Puerto Rico se unen en la lucha para proclamar el Día de la Prevención del Cáncer de Próstata, primera causa de muerte por cáncer entre los hombres en la isla

August 12, 2021

miR Scientific Hires Big-Pharma Executive Erik Johnson as New Chief Operating Officer

June 3, 2021

miR Scientific to Present the Award-Winning Prostate Cancer Application of its Liquid Biopsy Disease Management Platform at the Jefferies Virtual Healthcare Conference

February 25, 2021

miR Scientific to Present the Prostate Cancer Application of its Liquid Biopsy miR Disease Management Platform® at the 12th Annual Prostate Cancer Awareness Day (PCAD) at the Massachusetts State House

January 11, 2021

miR Scientific to Present the Prostate Cancer Application of its Liquid Biopsy Disease Management Platform at the 39th Annual J.P. Morgan Healthcare Conference

November 2, 2020

miR Scientific y el gobierno de Puerto Rico anuncian un convenio de cooperación sin precedentes para la evaluación del impacto y el despliegue de su prueba de biopsia líquida de cáncer de próstata en Puerto Rico

November 2, 2020

miR Scientific and Puerto Rico Government Announce Pioneering Cooperation Agreement to Evaluate Impact and Deployment of its Prostate Cancer Liquid Biopsy Test in Puerto Rico

October 13, 2020

miR Scientific announces FDA Breakthrough Device Designation for its Prostate Cancer Liquid Biopsy Test

September 14, 2020

miR Scientific's Breakthrough Sentinel Disease Management Platform Receives 2020 Innovation Award

September 8, 2020

miR Scientific on Yahoo Finance

August 10, 2020

miR Scientific Announces Validation of its Urine Based, Non-Invasive Prostate Cancer Test Published in the Journal of Urology

August 2, 2020

miR Scientific Named a Finalist in the Fierce Innovation Awards - Life Sciences Edition 2020

February 13, 2020

miR Scientific Presents Breakthrough New Data on the miR Scientific Sentinel™

January 21, 2020

miR Scientific® Introduces New Paradigm for Precision Medicine at PMWC 2020

March 18, 2019

miR Scientific Presents a New Non-invasive Test for Identifying Clinically Significant Prostate Cancer

July 20, 2018

miR Scientific to Present Novel Array Technologies for Diagnosis and Prognosis of Urogenital Cancers at the 2018 ASCO Annual Meeting

July 9, 2018

miR Scientific Appoints Laurence Klotz, M.D., FRCSC, as Chief Medical Officer

Media

May 13, 2022

A urinary exosome assay interrogating small non-coding RNAs accurately identifies and stratifies prostate cancer into low- intermediate- or high-risk disease.

September 13, 2021

Novel Urine-Based Test Evaluated in Prostate Cancer Detection and Risk Stratification

July 22, 2021

This Founder Has Partnered With A Renowned Researcher-His Dad-To Transform Prostate Cancer Diagnostics

March 29, 2021

Prostatepedia March 2021: Sam Salman, Urine-based Liquid Biopsy Testing

November 19, 2020

Puerto Rico to Test miR’s ‘Liquid Biopsy’ in Detecting Prostate Cancers

October 26, 2020

FDA grants breakthrough designation to urine-based liquid biopsy for prostate cancer

August 14, 2020

Classification of Prostate Cancer Using Tests for Small Noncoding RNAs in Urinary Exosomes

August 11, 2020

Forbes: A Test Affecting Every Man’s Life Will Soon Be On The Market

April 6, 2020

miR Scientific Validates Urine-Based Cancer Tests, Awaits NYState Approval

March 6, 2020

3 New miR Scientific Urine Tests Diagnose, Classify Prostate Cancer, Data Shows

April 15, 2019

miR Scientific: Spotting Aggression With RNA in Urine

March 28, 2019

miR Scientific Prepares to Launch Tests for Prostate, Bladder Cancer

October 4, 2018

miR Scientific Presents at 2018 World Urological Oncology Federation Conference

July 20, 2018

miR Scientific Prepares Launch of First Clinical Cancer Test, Buoyed by New Data